Company Overview
ORCHESTRA BIOMED HOLDINGS, INC.
OBIORevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
33M
2025 FY
Net Income
-53M
2025 FY
Shares Outstanding
48M
2025 FY
EPS
-1.11USD
2025 FY
Company Information
SIC Code
3841
CIK Code
1814114
Exchange
Nasdaq
Location
US